ARIAD PHARMACEUTICALS INC's ticker is and the CUSIP is 04033A900. A total of 3 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $808,000 | +353.9% | 1,265 | +388.4% | 0.04% | +566.7% |
| Q4 2014 | $178,000 | -85.5% | 259 | -88.6% | 0.01% | -87.2% |
| Q3 2014 | $1,227,000 | +643.6% | 2,272 | +777.2% | 0.05% | +571.4% |
| Q2 2014 | $165,000 | -97.2% | 259 | -96.4% | 0.01% | -97.9% |
| Q1 2014 | $5,819,000 | +74.8% | 7,220 | +48.0% | 0.33% | +53.8% |
| Q4 2013 | $3,328,000 | +107.9% | 4,880 | +460.9% | 0.21% | +103.8% |
| Q3 2013 | $1,601,000 | +211.5% | 870 | +195.9% | 0.10% | +205.9% |
| Q2 2013 | $514,000 | – | 294 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 136,200 | $2,382,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 294 | $514,000 | 0.03% |
| Citadel Advisors | 65,800 | $1,151,000 | 0.00% |